CervoMed amends warrant cap; chairman's trust exercises for 495,959 shares

CervoMed Inc.

On Feb 26, 2024, CervoMed amended its pre-funded warrant held by Joshua S. Boger's trust, removing 9.99% beneficial ownership restriction.
Immediately after, the trust cashlessly exercised the warrant, receiving 495,959 shares of common stock.
Post-exercise, total shares outstanding increased to 6,170,479 as of Feb 27, 2024.
Joshua S. Boger, Ph.D., chair of board, is sole trustee; trust now holds substantial stake.

item 1.01 item 3.03 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

CervoMed Inc. amended Amendment with The Joshua S. Boger 2021 Trust DTD 12/09/2021 (effective 2024-02-26).

Action: amendment
Counterparty: The Joshua S. Boger 2021 Trust DTD 12/09/2021
Effective: 2024-02-26

Exact text from the filing

☐ 1 Item 1.01 Entry into a Material Definitive Agreement Amendment to Pre-Funded Warrant As previously disclosed, on August 16, 2023, CervoMed Inc.

View on SEC.gov

754 material agreements filed in the last 30 days. Browse all material agreements →

CervoMed Inc. filing history →

Source: SEC EDGAR

accession 0001437749-24-005900

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.